loading...| Preferred Name |
balsalazide |
| Synonyms |
Colazal |
| ID |
http://purl.bioontology.org/ontology/MESH/C038637 |
| altLabel |
Colazal BX661A Benzoic acid, 5-((4-(((2-carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxy-, disodium salt balsalazide disodium BX 661A Colazide balsalazine 5-(carboxyethylcarbamoyl-4-phenylazo)salicylic acid |
| cui |
C0595402 C0525844 C0595398 C2742039 C0052940 C0939297 |
| HM |
D010659 D019804 |
| II |
D011355 D003093 D015212 |
| Inverse of RB |
P80AL8J7ZP |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
19830811 |
| MeSH Frequency |
82 |
| MMR |
20141022 |
| notation |
C038637 |
| PA |
D005765 D000894 |
| PI |
*AMINOSALICYLIC ACIDS (1983-2006) |
| prefLabel |
balsalazide |
| RR |
82101-18-6 (balsalazide) |
| SC |
1 |
| Scope Statement |
a mesalamine 5-aminosalicylate prodrug; 99% of ingested drug remains intact through the stomach and is delivered to and activated in the colon; used for inflammatory bowel disease, ulcerative colitis and radiation-induced proctosigmoiditis but avoided in patients with known hypersensitivity reaction to salicylates or mesalamine; structure in first source |
| SRC |
Dig Dis Sci 1983;28(7):609 |
| TERMUI |
T146209 T622278 T146206 T146207 T461570 T761601 T461571 T146208 |
| TH |
US FDA SRS (2013) NLM (2010) NLM (2001) NLM (1983) INN (19XX) UK |
| tui |
T109 T121 |